[{"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-001", "question": "A 34-year-old woman at 32 weeks gestation presents with hemodynamic instability after sudden right upper quadrant pain. CT angiography demonstrates rupture of a 12 cm hepatic hemangioma with active extravasation and consumptive coagulopathy (platelets 45,000, INR 2.3). What is the definitive management strategy that optimizes maternal-fetal survival?", "options": ["A) Emergency cesarean section followed by immediate right hepatectomy", "B) Immediate exploratory laparotomy with hepatic artery ligation and packing", "C) Hepatic artery embolization with gelatin sponge, delayed cesarean section at 34 weeks", "D) Emergent cesarean section with concurrent hepatic artery embolization in hybrid OR", "E) Staged approach: hepatic artery embolization first, then cesarean section once coagulopathy corrects"], "answer": "E", "answer_index": 4, "explanation": "In third-trimester ruptured giant hepatic hemangioma with Kasabach-Merritt phenomenon, staged management with hepatic artery embolization first to control bleeding and reverse coagulopathy, followed by semi-elective cesarean section, yields superior maternal-fetal outcomes compared to simultaneous or surgery-first approaches. Embolization with gelatin sponge preserves future liver function while controlling hemorrhage.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a life-threatening ruptured hepatic hemangioma with active extravasation and consumptive coagulopathy at 32 weeks gestation. Key discriminating findings: hemodynamic instability, active bleeding, severe coagulopathy (platelets 45,000, INR 2.3), viable fetus at 32 weeks. The critical missing detail is the degree of maternal hemodynamic instability. If the patient is in hemorrhagic shock requiring immediate resuscitation, emergent laparotomy (B) or hybrid approach (D) would be indicated. If relatively stable, staged embolization-first (E) is reasonable. The keyed answer (E) assumes sufficient stability to delay surgery, but 'hemodynamic instability' typically implies urgent intervention is needed. Options B, D, and E are all defensible depending on the severity of instability. The rationale's claim about Kasabach-Merritt phenomenon is questionable—this typically refers to thrombocytopenia with vascular tumors in infants, not adult hemangioma rupture. Medical accuracy issue: The management hierarchy for ruptured hemangioma with active extravasation and instability is not clearly established to favor staged approach universally. Minimal fix: Specify 'relative hemodynamic stability after initial resuscitation' or 'unstable requiring immediate intervention' to guide a unique answer.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a life-threatening ruptured hepatic hemangioma with active extravasation and consumptive coagulopathy at 32 weeks gestation. Key discriminating findings: hemodynamic instability, active bleeding, severe coagulopathy (platelets 45,000, INR 2.3), viable fetus at 32 weeks. The critical missing detail is the degree of maternal hemodynamic instability. If the patient is in hemorrhagic shock requiring immediate resuscitation, emergent laparotomy (B) or hybrid approach (D) would be indicated. If relatively stable, staged embolization-first (E) is reasonable. The keyed answer (E) assumes sufficient stability to delay surgery, but 'hemodynamic instability' typically implies urgent intervention is needed. Options B, D, and E are all defensible depending on the severity of instability. The rationale's claim about Kasabach-Merritt phenomenon is questionable—this typically refers to thrombocytopenia with vascular tumors in infants, not adult hemangioma rupture. Medical accuracy issue: The management hierarchy for ruptured hemangioma with active extravasation and instability is not clearly established to favor staged approach universally. Minimal fix: Specify 'relative hemodynamic stability after initial resuscitation' or 'unstable requiring immediate intervention' to guide a unique answer.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-002", "question": "A 68-year-old man with end colostomy presents with a 6 cm parastomal hernia and 8 cm prolapse through the fascial defect. He has failed conservative management with hernia belt. What is the optimal surgical repair technique and mesh configuration?", "options": ["A) Laparoscopic keyhole repair with heavyweight polypropylene mesh", "B) Open Sugarbaker repair with lightweight macroporous polypropylene mesh", "C) Laparoscopic modified Sugarbaker with dual-layer composite mesh (ePTFE/polypropylene)", "D) Open keyhole repair with biologic mesh (porcine dermis)", "E) Laparoscopic sandwich repair with two lightweight polypropylene meshes"], "answer": "B", "answer_index": 1, "explanation": "For parastomal hernia with significant prolapse, open Sugarbaker repair with lightweight macroporous polypropylene mesh provides superior recurrence prevention while allowing parastomal bowel mobility. The Sugarbaker configuration prevents mesh erosion by avoiding circumferential stoma encirclement, and lightweight mesh reduces infection risk in contaminated fields compared to composite or biologic meshes.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 68-year-old man with end colostomy, 6 cm parastomal hernia, 8 cm prolapse, and failed conservative management requiring surgical repair. Key discriminating findings: significant hernia size, prolapse component, failed conservative therapy. The question asks for \\\"optimal\\\" technique and mesh configuration but lacks critical details that determine best approach: patient comorbidities, contamination status, prior repairs, surgeon expertise, and whether laparoscopic approach is feasible. The keyed answer (B: open Sugarbaker with lightweight polypropylene) is defensible based on good outcomes in literature. However, option C (laparoscopic modified Sugarbaker with composite mesh) is equally defensible—laparoscopic Sugarbaker is widely accepted with excellent outcomes, and composite mesh is standard for intraperitoneal placement to prevent adhesions. The rationale's claim that lightweight mesh \\\"reduces infection risk in contaminated fields\\\" is unsupported—the stem never establishes contamination. Both open and laparoscopic Sugarbaker approaches have strong evidence; without specifying patient factors favoring one approach, both B and C are defensible. Main logical issue: underspecification (U) leading to multiple defensible answers (M). Minimal fix: specify patient factors (e.g., \\\"significant adhesions from prior surgery\\\" favoring open, or \\\"no contraindications to laparoscopy\\\" favoring minimally invasive).\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 68-year-old man with end colostomy, 6 cm parastomal hernia, 8 cm prolapse, and failed conservative management requiring surgical repair. Key discriminating findings: significant hernia size, prolapse component, failed conservative therapy. The question asks for \"optimal\" technique and mesh configuration but lacks critical details that determine best approach: patient comorbidities, contamination status, prior repairs, surgeon expertise, and whether laparoscopic approach is feasible. The keyed answer (B: open Sugarbaker with lightweight polypropylene) is defensible based on good outcomes in literature. However, option C (laparoscopic modified Sugarbaker with composite mesh) is equally defensible—laparoscopic Sugarbaker is widely accepted with excellent outcomes, and composite mesh is standard for intraperitoneal placement to prevent adhesions. The rationale's claim that lightweight mesh \"reduces infection risk in contaminated fields\" is unsupported—the stem never establishes contamination. Both open and laparoscopic Sugarbaker approaches have strong evidence; without specifying patient factors favoring one approach, both B and C are defensible. Main logical issue: underspecification (U) leading to multiple defensible answers (M). Minimal fix: specify patient factors (e.g., \"significant adhesions from prior surgery\" favoring open, or \"no contraindications to laparoscopy\" favoring minimally invasive).", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-003", "question": "A 3-year-old child with bilateral retinoblastoma has persistent class 3 vitreous seeds (vitreous clouds) in the right eye after six cycles of systemic chemotherapy and three intravitreal melphalan injections (30 µg). Examination shows tumor regression but diffuse non-confluent vitreous opacities. What is the next definitive management step?", "options": ["A) Increase intravitreal melphalan dose to 50 µg weekly for three doses", "B) Plaque brachytherapy with 125I to deliver 40 Gy to vitreous base", "C) Enucleation with histopathologic risk factor assessment", "D) Intravitreal topotecan 20 µg alternating with melphalan every 2 weeks", "E) External beam radiation therapy 45 Gy to entire globe"], "answer": "D", "answer_index": 3, "explanation": "For persistent class 3 vitreous seeds after standard melphalan, alternating intravitreal topotecan with melphalan provides synergistic tumoricidal activity while avoiding retinal toxicity from dose escalation. This protocol achieves 85% globe salvage for refractory seeds compared to 40% with continued melphalan alone, and avoids the late effects of external beam radiation in hereditary retinoblastoma.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes persistent class 3 vitreous seeds after extensive treatment (6 cycles systemic chemo + 3 intravitreal melphalan injections at 30 µg). Key discriminating findings: bilateral retinoblastoma (hereditary), tumor regression, persistent diffuse non-confluent vitreous opacities. The question asks for \\\"next definitive management.\\\" The keyed answer (D: alternating topotecan/melphalan) assumes continued globe salvage is the goal and that this specific alternating protocol is standard. However, the stem never explicitly states that globe salvage remains feasible or desired after this degree of treatment failure. Option C (enucleation) could be equally defensible as \\\"definitive\\\" management for refractory disease, particularly given the bilateral nature (one eye can be preserved). The rationale cites 85% salvage with alternating agents vs 40% with melphalan alone, but these data are not universally established as standard-of-care, and the choice between aggressive salvage vs enucleation depends on unstated factors (visual potential, family preference, extent of tumor). Medical accuracy: The alternating protocol exists in literature but is not universally adopted as definitive standard. Minimal fix: Specify \\\"while attempting globe preservation\\\" or provide additional details confirming salvageability to make D uniquely best.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes persistent class 3 vitreous seeds after extensive treatment (6 cycles systemic chemo + 3 intravitreal melphalan injections at 30 µg). Key discriminating findings: bilateral retinoblastoma (hereditary), tumor regression, persistent diffuse non-confluent vitreous opacities. The question asks for \"next definitive management.\" The keyed answer (D: alternating topotecan/melphalan) assumes continued globe salvage is the goal and that this specific alternating protocol is standard. However, the stem never explicitly states that globe salvage remains feasible or desired after this degree of treatment failure. Option C (enucleation) could be equally defensible as \"definitive\" management for refractory disease, particularly given the bilateral nature (one eye can be preserved). The rationale cites 85% salvage with alternating agents vs 40% with melphalan alone, but these data are not universally established as standard-of-care, and the choice between aggressive salvage vs enucleation depends on unstated factors (visual potential, family preference, extent of tumor). Medical accuracy: The alternating protocol exists in literature but is not universally adopted as definitive standard. Minimal fix: Specify \"while attempting globe preservation\" or provide additional details confirming salvageability to make D uniquely best.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-004", "question": "A 45-year-old recreational athlete presents 8 weeks after feeling a 'pop' in his knee. Examination reveals a chronic patellar tendon rupture with 7 cm retraction gap and inability to perform straight leg raise. MRI shows tendon degeneration but intact retinaculum. What is the optimal reconstruction technique?", "options": ["A) Primary repair with Krackow sutures and wire augmentation", "B) Ipsilateral hamstring autograft reconstruction through bone tunnels", "C) Contralateral bone-patellar tendon-bone autograft with interference screws", "D) Achilles tendon allograft with patellar bone block fixation", "E) Staged reconstruction: tendon lengthening first, then primary repair"], "answer": "C", "answer_index": 2, "explanation": "For chronic patellar tendon rupture with >6 cm gap, contralateral bone-patellar tendon-bone autograft provides optimal biomechanical strength and facilitates early mobilization. The graft's bone blocks allow secure interference screw fixation in patellar and tibial tunnels, restoring native tendon length and avoiding the quadriceps lag associated with hamstring or allograft reconstructions.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a chronic patellar tendon rupture (8 weeks, 7 cm retraction, failed straight leg raise, tendon degeneration). Key discriminating findings: chronic timeline, large gap (>6 cm), inability to perform SLR, intact retinaculum. The question asks for \\\"optimal\\\" reconstruction technique. The keyed answer (C: contralateral BTB autograft) is defensible based on the rationale provided—bone blocks allow secure fixation and restore length. However, option D (Achilles allograft with bone block) is equally defensible: Achilles allografts are widely used for chronic patellar tendon reconstruction, offer similar bone-block fixation advantages, avoid donor-site morbidity from the contralateral knee, and have comparable biomechanical properties. The stem provides no contraindication to allograft use (patient age 45, recreational athlete—not elite). Both C and D represent accepted surgical approaches for this scenario in orthopedic literature. The item lacks discriminating details (e.g., patient preference regarding donor site, surgeon expertise, allograft availability) needed to definitively favor one over the other. Medical accuracy: The keyed answer is medically sound but not uniquely superior. Minimal fix: Add stem detail contraindicating allograft (e.g., young elite athlete requiring fastest return, or specify \\\"autograft preferred\\\") or remove option D.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a chronic patellar tendon rupture (8 weeks, 7 cm retraction, failed straight leg raise, tendon degeneration). Key discriminating findings: chronic timeline, large gap (>6 cm), inability to perform SLR, intact retinaculum. The question asks for \"optimal\" reconstruction technique. The keyed answer (C: contralateral BTB autograft) is defensible based on the rationale provided—bone blocks allow secure fixation and restore length. However, option D (Achilles allograft with bone block) is equally defensible: Achilles allografts are widely used for chronic patellar tendon reconstruction, offer similar bone-block fixation advantages, avoid donor-site morbidity from the contralateral knee, and have comparable biomechanical properties. The stem provides no contraindication to allograft use (patient age 45, recreational athlete—not elite). Both C and D represent accepted surgical approaches for this scenario in orthopedic literature. The item lacks discriminating details (e.g., patient preference regarding donor site, surgeon expertise, allograft availability) needed to definitively favor one over the other. Medical accuracy: The keyed answer is medically sound but not uniquely superior. Minimal fix: Add stem detail contraindicating allograft (e.g., young elite athlete requiring fastest return, or specify \"autograft preferred\") or remove option D.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-005", "question": "A 28-year-old man presents 6 hours after penile trauma during intercourse. Examination reveals swelling, deformity, and blood at the meatus. Retrograde urethrogram shows extravasation at the bulbar urethra without contrast reaching the bladder. What is the definitive surgical management?", "options": ["A) Immediate exploration via circumferential subcoronal incision with primary urethral anastomosis", "B) Delayed reconstruction after 3 months with buccal mucosa graft urethroplasty", "C) Suprapubic catheter placement with conservative management", "D) Immediate exploration with urethral repair over catheter without anastomosis", "E) Endoscopic urethral realignment with catheter stenting"], "answer": "D", "answer_index": 3, "explanation": "Penile fracture with concomitant partial urethral injury requires immediate exploration via circumferential degloving incision. Most urethral injuries are partial disruptions that can be repaired primarily over a catheter without tension-free anastomosis, preserving urethral length. Formal graft urethroplasty is reserved for complete transections or delayed presentations, while endoscopic management misses associated corporal injuries.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - option B is the correct answer for complete bulbar urethral disruption. Key stem clues: (1) retrograde urethrogram showing extravasation at bulbar urethra WITHOUT contrast reaching bladder indicates complete urethral disruption/transection, not partial injury; (2) blood at meatus confirms urethral involvement; (3) penile fracture context. The critical discriminator is the RUG finding - absence of contrast in bladder definitively indicates complete disruption. For complete bulbar urethral disruptions, current gold-standard management is suprapubic catheter placement acutely followed by delayed urethroplasty (typically 3 months) with buccal mucosa graft, making B correct. Option D describes management for partial urethral injuries where some contrast passes. The explanation contradicts the stem by calling this a 'partial disruption' when the RUG clearly shows complete obstruction. Option A is anatomically incorrect (circumferential subcoronal incision is for penile fracture, not bulbar urethral injury which requires perineal approach). Medical accuracy issue: The keyed answer and rationale misinterpret the RUG findings. Minimal fix: Change key to B, or modify stem to show contrast reaching bladder (indicating partial injury) to support key D.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - option B is the correct answer for complete bulbar urethral disruption. Key stem clues: (1) retrograde urethrogram showing extravasation at bulbar urethra WITHOUT contrast reaching bladder indicates complete urethral disruption/transection, not partial injury; (2) blood at meatus confirms urethral involvement; (3) penile fracture context. The critical discriminator is the RUG finding - absence of contrast in bladder definitively indicates complete disruption. For complete bulbar urethral disruptions, current gold-standard management is suprapubic catheter placement acutely followed by delayed urethroplasty (typically 3 months) with buccal mucosa graft, making B correct. Option D describes management for partial urethral injuries where some contrast passes. The explanation contradicts the stem by calling this a 'partial disruption' when the RUG clearly shows complete obstruction. Option A is anatomically incorrect (circumferential subcoronal incision is for penile fracture, not bulbar urethral injury which requires perineal approach). Medical accuracy issue: The keyed answer and rationale misinterpret the RUG findings. Minimal fix: Change key to B, or modify stem to show contrast reaching bladder (indicating partial injury) to support key D.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-006", "question": "A 52-year-old woman develops clear rhinorrhea 3 days after endoscopic sinus surgery for revision frontal sinusitis. Intraoperative findings showed a 3 mm defect in the posterior table of the right frontal sinus. What is the optimal reconstruction method?", "options": ["A) Nasoseptal flap pedicled on posterior septal artery", "B) Middle turbinate flap with preservation of conchal crest attachment", "C) Free mucosal graft from inferior turbinate with tissue sealant", "D) Fat graft plugging with fascia lata overlay", "E) Synthetic dural substitute with fibrin glue"], "answer": "B", "answer_index": 1, "explanation": "For posterior table frontal sinus defects, the middle turbinate flap provides superior reach and vascularity compared to nasoseptal flaps. Preserving the conchal crest attachment maintains the axial blood supply from the sphenopalatine artery, ensuring graft survival in the poorly vascularized frontal sinus. Free grafts and synthetic materials have high failure rates in this location due to gravitational stress and limited recipient bed vascularity.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes clear rhinorrhea 3 days post-op with a 3mm posterior table defect but critically omits whether CSF leak is confirmed (beta-2 transferrin, halo sign) versus simple rhinorrhea. This distinction is essential: CSF leaks require vascularized flaps, while simple defects may need only bone repair or observation. Key B (middle turbinate flap) assumes CSF leak requiring reconstruction, but the nasoseptal flap (A) is the gold-standard vascularized flap for skull base CSF leaks in endoscopic sinus surgery, with superior reach to frontal recess and robust sphenopalatine blood supply. The rationale's claim that middle turbinate has 'superior reach' to frontal sinus contradicts standard practice where nasoseptal flaps are preferred for anterior skull base/frontal defects. Without CSF confirmation, options A and B are equally defensible, and even D (fat/fascia) is reasonable for confirmed leaks. Medical accuracy issues: The teaching point misrepresents flap selection hierarchy; nasoseptal flaps are standard for frontal skull base defects. Minimal fix: Specify 'confirmed CSF leak with beta-2 transferrin positive' and clarify why nasoseptal flap is contraindicated (e.g., prior septal surgery, inadequate pedicle length documented intraoperatively).\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes clear rhinorrhea 3 days post-op with a 3mm posterior table defect but critically omits whether CSF leak is confirmed (beta-2 transferrin, halo sign) versus simple rhinorrhea. This distinction is essential: CSF leaks require vascularized flaps, while simple defects may need only bone repair or observation. Key B (middle turbinate flap) assumes CSF leak requiring reconstruction, but the nasoseptal flap (A) is the gold-standard vascularized flap for skull base CSF leaks in endoscopic sinus surgery, with superior reach to frontal recess and robust sphenopalatine blood supply. The rationale's claim that middle turbinate has 'superior reach' to frontal sinus contradicts standard practice where nasoseptal flaps are preferred for anterior skull base/frontal defects. Without CSF confirmation, options A and B are equally defensible, and even D (fat/fascia) is reasonable for confirmed leaks. Medical accuracy issues: The teaching point misrepresents flap selection hierarchy; nasoseptal flaps are standard for frontal skull base defects. Minimal fix: Specify 'confirmed CSF leak with beta-2 transferrin positive' and clarify why nasoseptal flap is contraindicated (e.g., prior septal surgery, inadequate pedicle length documented intraoperatively).", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-007", "question": "A 62-year-old man with left hemiplegia 4 months post-stroke has severe shoulder pain and 2 cm inferior subluxation on exam. EMG shows spastic co-contraction of posterior deltoid and supraspinatus without voluntary motor unit recruitment. What is the optimal botulinum toxin injection protocol?", "options": ["A) 100 units incobotulinumtoxinA divided between posterior deltoid and supraspinatus", "B) 200 units onabotulinumtoxinA injected into subscapularis and pectoralis major only", "C) 50 units abobotulinumtoxinA into supraspinatus with ultrasound guidance", "D) 150 units incobotulinumtoxinA into posterior deltoid, supraspinatus, and upper trapezius", "E) 75 units onabotulinumtoxinA into posterior deltoid only"], "answer": "A", "answer_index": 0, "explanation": "For spasticity-driven post-stroke shoulder pain with subluxation, EMG-guided injection of 100 units incobotulinumtoxinA divided between posterior deltoid and supraspinatus reduces painful co-contraction while preserving anterior deltoid function for shoulder flexion. Targeting only internal rotators (subscapularis/pectoralis) worsens subluxation, and higher doses cause excessive weakness. The 1:1 conversion ratio of incobotulinumtoxinA provides predictable effect duration.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes post-stroke shoulder pain with inferior subluxation and EMG showing spastic co-contraction of posterior deltoid and supraspinatus. The clinical problem is selecting optimal botulinum toxin protocol for spasticity-driven shoulder pain. Key discriminating findings: 4-month post-stroke, left hemiplegia, severe shoulder pain, 2cm inferior subluxation, spastic co-contraction of posterior deltoid/supraspinatus. Main logical issues: (1) The stem lacks critical information about which muscles are causing the subluxation versus which are spastic. Inferior subluxation typically results from weakness of superior stabilizers (supraspinatus, deltoid), not their spasticity. (2) The rationale claims targeting these muscles 'reduces painful co-contraction' but injecting botulinum toxin into already-weak muscles causing subluxation would worsen the subluxation. (3) Multiple dosing protocols could be defensible depending on unstated clinical context. (4) The conversion ratio claim (1:1 incobotulinumtoxinA) is medically questionable—standard conversion is approximately 1:1 for ona- to incobo-, but clinical equivalence varies. Medical accuracy issues: The pathophysiology is internally inconsistent—spastic co-contraction of superior stabilizers would not typically cause inferior subluxation. Minimal fix: Clarify which muscles are hypertonic versus weak, and specify whether subluxation is from spasticity or flaccidity.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes post-stroke shoulder pain with inferior subluxation and EMG showing spastic co-contraction of posterior deltoid and supraspinatus. The clinical problem is selecting optimal botulinum toxin protocol for spasticity-driven shoulder pain. Key discriminating findings: 4-month post-stroke, left hemiplegia, severe shoulder pain, 2cm inferior subluxation, spastic co-contraction of posterior deltoid/supraspinatus. Main logical issues: (1) The stem lacks critical information about which muscles are causing the subluxation versus which are spastic. Inferior subluxation typically results from weakness of superior stabilizers (supraspinatus, deltoid), not their spasticity. (2) The rationale claims targeting these muscles 'reduces painful co-contraction' but injecting botulinum toxin into already-weak muscles causing subluxation would worsen the subluxation. (3) Multiple dosing protocols could be defensible depending on unstated clinical context. (4) The conversion ratio claim (1:1 incobotulinumtoxinA) is medically questionable—standard conversion is approximately 1:1 for ona- to incobo-, but clinical equivalence varies. Medical accuracy issues: The pathophysiology is internally inconsistent—spastic co-contraction of superior stabilizers would not typically cause inferior subluxation. Minimal fix: Clarify which muscles are hypertonic versus weak, and specify whether subluxation is from spasticity or flaccidity.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-008", "question": "A 71-year-old man with history of scalp radiation for basal cell carcinoma 20 years ago develops a 5 cm recurrent tumor with 2 cm calvarial erosion. After oncologic resection, there is a full-thickness calvarial defect with dural exposure. What is the optimal reconstruction?", "options": ["A) Latissimus dorsi myocutaneous free flap with split-thickness skin graft", "B) Omental free flap with vascularized bone graft", "C) Pericranial flap rotation with split calvarial graft", "D) Latissimus dorsi muscle-only free flap with skin graft and delayed cranioplasty", "E) Anterolateral thigh fasciocutaneous flap with titanium mesh"], "answer": "D", "answer_index": 3, "explanation": "In irradiated scalp defects with calvarial exposure, muscle-only free flaps (latissimus dorsi) provide robust vascularity to compromised beds while allowing secondary skin grafting. The muscle conforms better to calvarial contours than fasciocutaneous flaps, and delayed cranioplasty after soft tissue healing reduces hardware exposure risk. Myocutaneous flaps are too bulky, and local pericranial flaps have unreliable vascularity in previously irradiated fields.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 71-year-old with recurrent basal cell carcinoma after prior scalp radiation, resulting in a full-thickness calvarial defect with dural exposure after oncologic resection. Key discriminating findings: (1) previously irradiated field (20 years prior), (2) full-thickness calvarial defect, (3) dural exposure requiring coverage. The clinical problem is selecting optimal reconstruction for a complex scalp defect in a compromised, irradiated wound bed. Option D (latissimus dorsi muscle-only free flap with skin graft and delayed cranioplasty) is the best answer because: muscle-only flaps provide excellent vascularity to irradiated beds, conform well to calvarial contours, allow skin grafting for coverage, and staged cranioplasty reduces hardware exposure risk in compromised tissue. Alternative analysis: A (myocutaneous flap) is excessively bulky for scalp reconstruction; B (omental flap) is unnecessarily complex when muscle flaps suffice; C (pericranial flap) has unreliable vascularity in irradiated fields and insufficient reach for large defects; E (fasciocutaneous flap with immediate mesh) risks hardware exposure in irradiated tissue. The item is medically accurate, reflecting current reconstructive principles for irradiated scalp defects. No logical flaws present. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 71-year-old with recurrent basal cell carcinoma after prior scalp radiation, resulting in a full-thickness calvarial defect with dural exposure after oncologic resection. Key discriminating findings: (1) previously irradiated field (20 years prior), (2) full-thickness calvarial defect, (3) dural exposure requiring coverage. The clinical problem is selecting optimal reconstruction for a complex scalp defect in a compromised, irradiated wound bed. Option D (latissimus dorsi muscle-only free flap with skin graft and delayed cranioplasty) is the best answer because: muscle-only flaps provide excellent vascularity to irradiated beds, conform well to calvarial contours, allow skin grafting for coverage, and staged cranioplasty reduces hardware exposure risk in compromised tissue. Alternative analysis: A (myocutaneous flap) is excessively bulky for scalp reconstruction; B (omental flap) is unnecessarily complex when muscle flaps suffice; C (pericranial flap) has unreliable vascularity in irradiated fields and insufficient reach for large defects; E (fasciocutaneous flap with immediate mesh) risks hardware exposure in irradiated tissue. The item is medically accurate, reflecting current reconstructive principles for irradiated scalp defects. No logical flaws present. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-009", "question": "A 28-year-old woman presents with progressive myelopathy over 6 months. MRI shows a holocord enhancing lesion from C2 to T9 with cystic components. Intraoperative neuromonitoring shows 60% amplitude reduction in motor evoked potentials after initial tumor debulking. What is the next surgical decision?", "options": ["A) Continue aggressive debulking despite signal changes", "B) Halt resection, perform duraplasty, and plan staged resection", "C) Switch to ultrasonic aspiration for gentler tumor removal", "D) Administer high-dose steroids and continue resection", "E) Perform en bloc resection of involved cord segments"], "answer": "B", "answer_index": 1, "explanation": "For holocord ependymoma, intraoperative neuromonitoring with >50% MEP amplitude reduction mandates immediate cessation of resection to prevent permanent neurologic deficit. Staged resection after allowing neural recovery (typically 3-6 months) achieves maximal safe cytoreduction. Continuing despite signal loss causes paraplegia, while en bloc resection is contraindicated in holocord lesions. Ultrasonic aspiration still transmits vibratory injury to compressed neural tissue.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best. The stem describes a 28-year-old woman with progressive myelopathy and a holocord enhancing lesion with cystic components (C2-T9), highly suggestive of ependymoma. The critical discriminating finding is intraoperative neuromonitoring showing 60% MEP amplitude reduction after initial debulking. Standard neurosurgical practice mandates halting resection when MEP amplitude drops >50% to prevent permanent neurologic injury. Option B correctly advocates stopping resection, performing duraplasty for decompression, and planning staged resection after neural recovery (3-6 months). Option A (continuing despite signal loss) risks paraplegia. Option C (ultrasonic aspiration) still transmits vibratory injury to already compromised neural tissue and ignores the MEP warning. Option D (steroids + continue) does not address the immediate risk signaled by MEP changes. Option E (en bloc resection) is contraindicated in holocord lesions spanning multiple segments. The item is logically valid with a unique best answer supported by established intraoperative neuromonitoring protocols. Medical accuracy is high, consistent with modern neurosurgical standards for intramedullary tumor resection. No fix needed; the item is well-constructed and educationally sound.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. The stem describes a 28-year-old woman with progressive myelopathy and a holocord enhancing lesion with cystic components (C2-T9), highly suggestive of ependymoma. The critical discriminating finding is intraoperative neuromonitoring showing 60% MEP amplitude reduction after initial debulking. Standard neurosurgical practice mandates halting resection when MEP amplitude drops >50% to prevent permanent neurologic injury. Option B correctly advocates stopping resection, performing duraplasty for decompression, and planning staged resection after neural recovery (3-6 months). Option A (continuing despite signal loss) risks paraplegia. Option C (ultrasonic aspiration) still transmits vibratory injury to already compromised neural tissue and ignores the MEP warning. Option D (steroids + continue) does not address the immediate risk signaled by MEP changes. Option E (en bloc resection) is contraindicated in holocord lesions spanning multiple segments. The item is logically valid with a unique best answer supported by established intraoperative neuromonitoring protocols. Medical accuracy is high, consistent with modern neurosurgical standards for intramedullary tumor resection. No fix needed; the item is well-constructed and educationally sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-010", "question": "A 35-year-old woman is diagnosed with WNT-activated medulloblastoma after gross total resection. Molecular profiling shows CTNNB1 mutation without TP53 alteration. What is the recommended craniospinal irradiation dose and chemotherapy approach?", "options": ["A) 36 Gy craniospinal with posterior fossa boost to 54 Gy plus adjuvant temozolomide", "B) 23.4 Gy craniospinal with boost to 54 Gy, no chemotherapy", "C) 30.6 Gy craniospinal with boost to 55.8 Gy plus concurrent vincristine", "D) 18 Gy craniospinal with boost to 50.4 Gy plus high-dose chemotherapy with stem cell rescue", "E) 36 Gy craniospinal with boost to 55.8 Gy plus cisplatin-based chemotherapy"], "answer": "B", "answer_index": 1, "explanation": "WNT-activated medulloblastoma in adults has >95% 5-year survival, allowing significant craniospinal dose de-escalation to 23.4 Gy with posterior fossa boost to 54 Gy while omitting chemotherapy, reducing neurocognitive and endocrine toxicity. This protocol is supported by COG ACNS1422 and SJMB12 trials. Standard doses cause unnecessary toxicity, and chemotherapy adds no survival benefit in this molecular subgroup.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best answer for an adult patient. Key stem clues: 35-year-old woman (adult), WNT-activated medulloblastoma, gross total resection, CTNNB1 mutation, no TP53 alteration. The question asks about treatment for an adult with WNT-activated medulloblastoma. The rationale cites pediatric trials (COG ACNS1422, SJMB12) that support dose de-escalation in children with WNT tumors. However, medulloblastoma in adults is treated differently than in children. Standard adult medulloblastoma protocols use 36 Gy craniospinal irradiation with boost to 54-55.8 Gy plus chemotherapy (typically cisplatin-based), regardless of molecular subgroup. While WNT tumors have excellent prognosis, the dose de-escalation strategy (23.4 Gy) cited in option B is derived from pediatric protocols to minimize neurocognitive effects in developing brains - a concern less applicable to adults. Option E (36 Gy CSI with boost plus cisplatin-based chemotherapy) represents standard adult treatment. The item conflates pediatric and adult treatment paradigms. Main medical accuracy issue: applying pediatric dose de-escalation protocols to adult patients without established evidence. Minimal fix: specify 'pediatric patient' in the stem or change the keyed answer to E for adult standard-of-care treatment.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best answer for an adult patient. Key stem clues: 35-year-old woman (adult), WNT-activated medulloblastoma, gross total resection, CTNNB1 mutation, no TP53 alteration. The question asks about treatment for an adult with WNT-activated medulloblastoma. The rationale cites pediatric trials (COG ACNS1422, SJMB12) that support dose de-escalation in children with WNT tumors. However, medulloblastoma in adults is treated differently than in children. Standard adult medulloblastoma protocols use 36 Gy craniospinal irradiation with boost to 54-55.8 Gy plus chemotherapy (typically cisplatin-based), regardless of molecular subgroup. While WNT tumors have excellent prognosis, the dose de-escalation strategy (23.4 Gy) cited in option B is derived from pediatric protocols to minimize neurocognitive effects in developing brains - a concern less applicable to adults. Option E (36 Gy CSI with boost plus cisplatin-based chemotherapy) represents standard adult treatment. The item conflates pediatric and adult treatment paradigms. Main medical accuracy issue: applying pediatric dose de-escalation protocols to adult patients without established evidence. Minimal fix: specify 'pediatric patient' in the stem or change the keyed answer to E for adult standard-of-care treatment.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-011", "question": "A 58-year-old man with mid-rectal cancer (cT3N1M0) has enlarged right obturator lymph node (8 mm) on staging MRI. The primary tumor is 5 cm from the anal verge. What is the optimal treatment sequence?", "options": ["A) Long-course chemoradiation (50.4 Gy) followed by total mesorectal excision without lateral dissection", "B) Short-course radiation (25 Gy) followed by extended lymphadenectomy including obturator nodes", "C) Chemoradiation (50.4 Gy) with boost to obturator node, then TME with selective lateral dissection if node persists", "D) Induction chemotherapy (FOLFOX) followed by chemoradiation and TME", "E) Total neoadjuvant therapy with consolidation chemotherapy then TME with bilateral lateral lymph node dissection"], "answer": "C", "answer_index": 2, "explanation": "For rectal cancer with suspicious lateral lymph node, chemoradiation with simultaneous integrated boost (60 Gy to node) followed by TME with selective lateral dissection only for radiologically persistent nodes balances local control and morbidity. Prophylactic lateral dissection causes unnecessary urinary and sexual dysfunction. The Japanese JCOG0212 trial showed selective dissection is non-inferior to routine dissection when nodes respond to radiation.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U (underspecified) leading to M (multiple defensible answers). Verdict: Not uniquely determinable. The vignette describes cT3N1M0 mid-rectal cancer with an 8mm right obturator node. Key discriminating findings: locally advanced rectal cancer, suspicious lateral pelvic node, low tumor location (5cm from anal verge). The question asks for optimal treatment sequence but lacks critical information: (1) geographic context (Western vs. Eastern practice patterns differ significantly regarding lateral lymph node dissection), (2) whether the 8mm node meets institutional criteria for \\\"suspicious\\\" (size alone is borderline), (3) patient fitness/preferences. The keyed answer (C) reflects a selective approach with boost and conditional lateral dissection, citing JCOG0212. However, option E (total neoadjuvant therapy with bilateral LLND) is equally defensible in centers following Japanese/Asian protocols where LLND is standard for lateral node involvement. Option A represents standard Western practice (long-course CRT+TME without routine lateral dissection) and is defensible if the node is considered adequately covered by standard fields. The item requires unstated assumptions about practice setting and institutional protocols to select a unique best answer. Main medical issue: the rationale oversimplifies geographic variation in lateral node management. Minimal fix: specify \\\"In a Western practice setting\\\" or provide node characteristics (SUV, morphology) that definitively indicate high-risk disease requiring selective dissection.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (underspecified) leading to M (multiple defensible answers). Verdict: Not uniquely determinable. The vignette describes cT3N1M0 mid-rectal cancer with an 8mm right obturator node. Key discriminating findings: locally advanced rectal cancer, suspicious lateral pelvic node, low tumor location (5cm from anal verge). The question asks for optimal treatment sequence but lacks critical information: (1) geographic context (Western vs. Eastern practice patterns differ significantly regarding lateral lymph node dissection), (2) whether the 8mm node meets institutional criteria for \"suspicious\" (size alone is borderline), (3) patient fitness/preferences. The keyed answer (C) reflects a selective approach with boost and conditional lateral dissection, citing JCOG0212. However, option E (total neoadjuvant therapy with bilateral LLND) is equally defensible in centers following Japanese/Asian protocols where LLND is standard for lateral node involvement. Option A represents standard Western practice (long-course CRT+TME without routine lateral dissection) and is defensible if the node is considered adequately covered by standard fields. The item requires unstated assumptions about practice setting and institutional protocols to select a unique best answer. Main medical issue: the rationale oversimplifies geographic variation in lateral node management. Minimal fix: specify \"In a Western practice setting\" or provide node characteristics (SUV, morphology) that definitively indicate high-risk disease requiring selective dissection.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-012", "question": "A 6-year-old child has a retroperitoneal lymphangioma extending from renal hilum to pelvis, causing refractory chylous ascites requiring weekly paracentesis. Imaging shows a multiloculated cystic mass with thin septations. What is the definitive management?", "options": ["A) Complete surgical excision via retroperitoneal approach", "B) Percutaneous sclerotherapy with doxycycline and ethanol", "C) Laparoscopic fenestration and omental marsupialization", "D) Observation with medium-chain triglyceride diet", "E) Retroperitoneal lymph node dissection with lymphatic ligation"], "answer": "B", "answer_index": 1, "explanation": "Large retroperitoneal lymphangiomas with chylous ascites are best managed with percutaneous sclerotherapy using doxycycline and ethanol, achieving 85% cure rate. The multiloculated nature makes complete surgical excision hazardous due to proximity to renal vessels and pancreas, with 40% recurrence and high morbidity. Sclerotherapy induces fibrosis of lymphatic channels while preserving adjacent structures, and is superior to laparoscopic fenestration for macrocystic lesions.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - complete surgical excision is the definitive management. The stem describes a 6-year-old with extensive retroperitoneal lymphangioma causing refractory chylous ascites requiring weekly paracentesis. Key discriminating findings: large multiloculated cystic mass extending renal hilum to pelvis, refractory symptoms requiring repeated intervention. The question explicitly asks for 'definitive management.' In pediatric lymphangiomas, complete surgical excision (Option A) is the gold standard definitive treatment when feasible, offering the best chance of cure and eliminating recurrence risk. While the rationale claims sclerotherapy achieves 85% cure rate, this contradicts established surgical literature showing excision as definitive therapy. Sclerotherapy (Option B) is typically reserved for cases where surgery is too risky or as adjunctive therapy, not as first-line definitive management in a child who can tolerate surgery. The rationale's claim that excision has 40% recurrence is inconsistent with modern surgical series. Option C (fenestration) is palliative. Option D (observation) fails given refractory symptoms. Option E is not standard. The item confuses 'definitive' with 'less invasive alternative.' Minimal fix: Either change the key to A, or reframe the question to ask for 'initial management in a high-surgical-risk patient' to justify sclerotherapy.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - complete surgical excision is the definitive management. The stem describes a 6-year-old with extensive retroperitoneal lymphangioma causing refractory chylous ascites requiring weekly paracentesis. Key discriminating findings: large multiloculated cystic mass extending renal hilum to pelvis, refractory symptoms requiring repeated intervention. The question explicitly asks for 'definitive management.' In pediatric lymphangiomas, complete surgical excision (Option A) is the gold standard definitive treatment when feasible, offering the best chance of cure and eliminating recurrence risk. While the rationale claims sclerotherapy achieves 85% cure rate, this contradicts established surgical literature showing excision as definitive therapy. Sclerotherapy (Option B) is typically reserved for cases where surgery is too risky or as adjunctive therapy, not as first-line definitive management in a child who can tolerate surgery. The rationale's claim that excision has 40% recurrence is inconsistent with modern surgical series. Option C (fenestration) is palliative. Option D (observation) fails given refractory symptoms. Option E is not standard. The item confuses 'definitive' with 'less invasive alternative.' Minimal fix: Either change the key to A, or reframe the question to ask for 'initial management in a high-surgical-risk patient' to justify sclerotherapy.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-013", "question": "A 67-year-old man has ocular surface squamous neoplasia involving 5 clock hours of limbus with anterior segment OCT showing 1.2 mm depth of invasion into peripheral cornea. There is no scleral invasion. What is the management?", "options": ["A) Enucleation with orbital implant", "B) Exenteration with adjuvant radiation therapy", "C) Globe-sparing tumor excision with lamellar keratoplasty and adjuvant plaque brachytherapy", "D) Topical interferon alpha-2b for 6 months", "E) Cryotherapy to tumor base with amniotic membrane transplantation"], "answer": "C", "answer_index": 2, "explanation": "Ocular surface squamous neoplasia with intraocular invasion <2 mm depth can be managed with globe-sparing lamellar keratoplasty to clear margins followed by adjuvant strontium-90 plaque brachytherapy (30 Gy to base). This achieves 90% local control while preserving vision. Enucleation is reserved for scleral invasion or recurrence. Topical therapy cannot penetrate intraocular extension, and cryotherapy alone is insufficient for invasive disease.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best. The vignette describes OSSN with 1.2 mm corneal stromal invasion (5 clock hours limbal involvement) without scleral invasion. Key discriminating findings: (1) invasive disease (1.2 mm depth), (2) no scleral involvement, (3) peripheral corneal location amenable to surgical excision. The keyed answer (C) – globe-sparing excision with lamellar keratoplasty plus adjuvant plaque brachytherapy – is the standard approach for invasive OSSN <2 mm depth without scleral invasion, achieving high local control while preserving the globe. Alternative assessment: (A) Enucleation is overly aggressive for non-scleral disease; (B) Exenteration is reserved for orbital invasion; (D) Topical interferon cannot penetrate 1.2 mm stromal invasion; (E) Cryotherapy alone is insufficient for invasive disease requiring margin clearance. Medical accuracy: The management algorithm (topical therapy for superficial disease, globe-sparing surgery with adjuvant radiation for limited invasion, enucleation for scleral invasion) aligns with ophthalmology oncology standards. The 2 mm depth threshold and 90% local control rate cited are consistent with published literature. No logical flaws; the stem provides sufficient detail (invasion depth, extent, absence of scleral involvement) to select a unique best answer. Minimal fix: None required; item is valid and accurate.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. The vignette describes OSSN with 1.2 mm corneal stromal invasion (5 clock hours limbal involvement) without scleral invasion. Key discriminating findings: (1) invasive disease (1.2 mm depth), (2) no scleral involvement, (3) peripheral corneal location amenable to surgical excision. The keyed answer (C) – globe-sparing excision with lamellar keratoplasty plus adjuvant plaque brachytherapy – is the standard approach for invasive OSSN <2 mm depth without scleral invasion, achieving high local control while preserving the globe. Alternative assessment: (A) Enucleation is overly aggressive for non-scleral disease; (B) Exenteration is reserved for orbital invasion; (D) Topical interferon cannot penetrate 1.2 mm stromal invasion; (E) Cryotherapy alone is insufficient for invasive disease requiring margin clearance. Medical accuracy: The management algorithm (topical therapy for superficial disease, globe-sparing surgery with adjuvant radiation for limited invasion, enucleation for scleral invasion) aligns with ophthalmology oncology standards. The 2 mm depth threshold and 90% local control rate cited are consistent with published literature. No logical flaws; the stem provides sufficient detail (invasion depth, extent, absence of scleral involvement) to select a unique best answer. Minimal fix: None required; item is valid and accurate.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-014", "question": "A 78-year-old woman falls and sustains a four-part proximal humerus fracture with head-split pattern and 2 cm medial calcar comminution. The greater tuberosity is fractured but not displaced. What is the optimal implant selection?", "options": ["A) Open reduction and internal fixation with locking plate and fibular allograft augmentation", "B) Hemiarthroplasty with cemented stem and tuberosity repair", "C) Reverse shoulder arthroplasty with 36 mm glenosphere and augmented baseplate", "D) Reverse shoulder arthroplasty with standard baseplate and tuberosity preservation", "E) Nonoperative management with sling and early passive motion"], "answer": "D", "answer_index": 3, "explanation": "In elderly patients with head-split fractures and intact tuberosities, reverse shoulder arthroplasty with standard baseplate and tuberosity preservation (not repair) provides superior forward elevation and reduces prosthetic instability. Augmented baseplates are unnecessary without glenoid bone loss, and tuberosity repair in reverse arthroplasty increases stiffness without functional benefit. ORIF has 60% failure rate in this pattern, and hemiarthroplasty requires functional rotator cuff.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 78-year-old with a complex four-part proximal humerus fracture including head-split pattern and significant medial calcar comminution. Key discriminating findings: elderly patient, four-part fracture, head-split component, 2cm medial calcar comminution, greater tuberosity fractured but not displaced. The keyed answer (D: reverse shoulder arthroplasty with standard baseplate and tuberosity preservation) is reasonable for this complex fracture in an elderly patient. However, option C (reverse shoulder arthroplasty with 36mm glenosphere and augmented baseplate) is equally defensible. The stem provides no information about glenoid bone quality or loss that would definitively exclude augmented baseplate consideration. The rationale states augmented baseplates are unnecessary without glenoid bone loss, but the stem never specifies glenoid status. Both D and C represent reverse shoulder arthroplasty approaches that are appropriate for this fracture pattern in an elderly patient. The distinction between standard versus augmented baseplate and specific glenosphere size cannot be determined from the vignette alone. Medical accuracy is reasonable (score 4) as reverse arthroplasty is appropriate for this complex fracture. Minimal fix: Add explicit statement about glenoid bone quality/integrity to justify standard baseplate selection.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 78-year-old with a complex four-part proximal humerus fracture including head-split pattern and significant medial calcar comminution. Key discriminating findings: elderly patient, four-part fracture, head-split component, 2cm medial calcar comminution, greater tuberosity fractured but not displaced. The keyed answer (D: reverse shoulder arthroplasty with standard baseplate and tuberosity preservation) is reasonable for this complex fracture in an elderly patient. However, option C (reverse shoulder arthroplasty with 36mm glenosphere and augmented baseplate) is equally defensible. The stem provides no information about glenoid bone quality or loss that would definitively exclude augmented baseplate consideration. The rationale states augmented baseplates are unnecessary without glenoid bone loss, but the stem never specifies glenoid status. Both D and C represent reverse shoulder arthroplasty approaches that are appropriate for this fracture pattern in an elderly patient. The distinction between standard versus augmented baseplate and specific glenosphere size cannot be determined from the vignette alone. Medical accuracy is reasonable (score 4) as reverse arthroplasty is appropriate for this complex fracture. Minimal fix: Add explicit statement about glenoid bone quality/integrity to justify standard baseplate selection.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-015", "question": "A 42-year-old woman has a 3 cm proximal urethral diverticulum containing multiple calculi on MRI. She has recurrent urinary tract infections and post-void dribbling. What is the optimal surgical approach?", "options": ["A) Transvaginal diverticulectomy with urethral reconstruction and stone extraction", "B) Endoscopic unroofing with laser lithotripsy of calculi", "C) Transvaginal marsupialization with stone extraction and layered closure", "D) Urethral dilation and transurethral stone extraction", "E) Laparoscopic diverticulectomy with robotic assistance"], "answer": "C", "answer_index": 2, "explanation": "Proximal urethral diverticulum with calculi is best managed via transvaginal marsupialization with complete stone extraction and multilayered closure (urethra, periurethral fascia, vaginal wall). This preserves urethral length and continence while eliminating the stone-bearing cavity. Formal diverticulectomy risks urethral stricture and incontinence. Endoscopic unroofing is inadequate for proximal lesions and leaves stone fragments. Laparoscopic approach offers no advantage for this extraperitoneal pathology.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: The keyed answer (C, marsupialization) is incorrect; the best answer is A (diverticulectomy with reconstruction). Key stem clues: 3 cm proximal urethral diverticulum with multiple calculi, recurrent UTIs, post-void dribbling. Main logical issue: The item has a unique best answer supported by current surgical standards, but the provided key does not match it. Main medical accuracy issue: The rationale incorrectly states that 'formal diverticulectomy risks urethral stricture and incontinence' and that marsupialization is preferred. Current urologic consensus holds that complete excision (diverticulectomy) with multilayered urethral reconstruction is the gold standard for symptomatic urethral diverticula, especially those containing calculi. Marsupialization is an older, less definitive technique that leaves diverticular tissue in situ and has higher recurrence rates. Modern surgical teaching emphasizes complete excision with careful layered closure to preserve continence and urethral integrity. The size (3 cm) and presence of stones further support complete excision over marsupialization. Minimal fix: Change the correct answer key from C to A, or rewrite the rationale to reflect current surgical standards favoring complete diverticulectomy.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: The keyed answer (C, marsupialization) is incorrect; the best answer is A (diverticulectomy with reconstruction). Key stem clues: 3 cm proximal urethral diverticulum with multiple calculi, recurrent UTIs, post-void dribbling. Main logical issue: The item has a unique best answer supported by current surgical standards, but the provided key does not match it. Main medical accuracy issue: The rationale incorrectly states that 'formal diverticulectomy risks urethral stricture and incontinence' and that marsupialization is preferred. Current urologic consensus holds that complete excision (diverticulectomy) with multilayered urethral reconstruction is the gold standard for symptomatic urethral diverticula, especially those containing calculi. Marsupialization is an older, less definitive technique that leaves diverticular tissue in situ and has higher recurrence rates. Modern surgical teaching emphasizes complete excision with careful layered closure to preserve continence and urethral integrity. The size (3 cm) and presence of stones further support complete excision over marsupialization. Minimal fix: Change the correct answer key from C to A, or rewrite the rationale to reflect current surgical standards favoring complete diverticulectomy.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-016", "question": "A 55-year-old man has left vocal fold paralysis 6 months after thyroidectomy, with persistent aspiration and breathy voice. EMG shows absent motor unit potentials. What is the optimal injection laryngoplasty material?", "options": ["A) Hyaluronic acid gel for temporary medialization", "B) Calcium hydroxylapatite paste for permanent augmentation", "C) Autologous fat injection for long-term volume restoration", "D) Gelfoam paste for temporary 3-month effect", "E) Polydimethylsiloxane for permanent irreversible medialization"], "answer": "B", "answer_index": 1, "explanation": "For permanent vocal fold paralysis with absent EMG potentials, calcium hydroxylapatite provides durable medialization without migration. Its high viscosity prevents particle dispersion, and it integrates into tissue without foreign body reaction. Hyaluronic acid and Gelfoam are temporary (<6 months) and unsuitable for permanent paralysis. Autologous fat has unpredictable resorption (50-80% at 1 year), and polydimethylsiloxane risks granuloma formation and airway compromise if overinjected.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 55-year-old man with left vocal fold paralysis 6 months post-thyroidectomy, persistent aspiration, breathy voice, and absent motor unit potentials on EMG (indicating permanent denervation). The question asks for the \\\"optimal\\\" injection laryngoplasty material. Key issue: Both calcium hydroxylapatite (B) and autologous fat (C) are defensible as permanent medialization options. While the rationale dismisses fat due to \\\"unpredictable resorption (50-80%)\\\", this actually means 20-50% retention—a clinically acceptable outcome for many surgeons who prefer autologous materials over synthetic ones. The stem provides no patient-specific factors (e.g., preference for synthetic vs. autologous, tolerance for revision, cost considerations) to discriminate between these two permanent options. Hyaluronic acid (A) and Gelfoam (D) are correctly eliminated as temporary. Polydimethylsiloxone (E) is rarely used due to complications. Medical accuracy: The characterization of calcium hydroxylapatite is accurate, but dismissing autologous fat as suboptimal oversimplifies clinical practice where both are standard permanent options. Minimal fix: Add stem detail specifying patient preference for synthetic material or single-procedure definitive treatment to uniquely favor calcium hydroxylapatite.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 55-year-old man with left vocal fold paralysis 6 months post-thyroidectomy, persistent aspiration, breathy voice, and absent motor unit potentials on EMG (indicating permanent denervation). The question asks for the \"optimal\" injection laryngoplasty material. Key issue: Both calcium hydroxylapatite (B) and autologous fat (C) are defensible as permanent medialization options. While the rationale dismisses fat due to \"unpredictable resorption (50-80%)\", this actually means 20-50% retention—a clinically acceptable outcome for many surgeons who prefer autologous materials over synthetic ones. The stem provides no patient-specific factors (e.g., preference for synthetic vs. autologous, tolerance for revision, cost considerations) to discriminate between these two permanent options. Hyaluronic acid (A) and Gelfoam (D) are correctly eliminated as temporary. Polydimethylsiloxone (E) is rarely used due to complications. Medical accuracy: The characterization of calcium hydroxylapatite is accurate, but dismissing autologous fat as suboptimal oversimplifies clinical practice where both are standard permanent options. Minimal fix: Add stem detail specifying patient preference for synthetic material or single-procedure definitive treatment to uniquely favor calcium hydroxylapatite.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-017", "question": "A 45-year-old man with T6 complete spinal cord injury has a stage 4 sacral pressure ulcer with positive probe-to-bone test and MRI showing marrow edema limited to cortex. He has been on antibiotics for 4 weeks with minimal improvement. What is definitive management?", "options": ["A) Continue suppressive antibiotics indefinitely with wound care", "B) Surgical debridement to bone with burr drilling, VAC therapy, then gluteal myocutaneous flap", "C) Radical debridement with partial sacrectomy and omental flap", "D) Transcutaneous bone biopsy and targeted IV antibiotics for 12 weeks", "E) Osteomyelitis excision with free latissimus dorsi muscle flap"], "answer": "B", "answer_index": 1, "explanation": "Stage 4 sacral ulcer with cortical osteomyelitis requires surgical debridement with burr drilling of exposed bone to bleeding cortex, followed by VAC therapy to prepare granulation tissue, then gluteal myocutaneous flap coverage. This achieves 85% healing rates. Partial sacrectomy is reserved for medullary involvement. Suppressive antibiotics alone fail in 70% of cases, and free flaps are unnecessary when local muscle is available and viable.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best. The vignette describes a 45-year-old paraplegic with stage 4 sacral pressure ulcer, positive probe-to-bone test, and MRI showing marrow edema limited to cortex (cortical osteomyelitis), with failed 4-week antibiotic trial. Key discriminating findings: (1) stage 4 ulcer with bone involvement, (2) cortical-only osteomyelitis (not medullary), (3) failed conservative management. The question asks for definitive management. Option B (surgical debridement with burr drilling, VAC, then gluteal myocutaneous flap) is the standard staged approach for cortical osteomyelitis in pressure ulcers: debride infected bone to bleeding cortex, prepare wound bed with negative pressure, then provide durable muscle flap coverage. Option A (suppressive antibiotics) fails in most cases without source control. Option C (partial sacrectomy) is overly aggressive for cortical-only disease; reserved for medullary involvement. Option D (biopsy and prolonged antibiotics) lacks surgical source control. Option E (free latissimus flap) is unnecessarily complex when local gluteal muscle is available. The keyed answer aligns with standard reconstructive ladder principles and pressure ulcer management guidelines. Medical accuracy: The staged approach and flap selection are appropriate. Minor issue: 85% healing rate cited in rationale is optimistic but within reported ranges. Minimal fix: None needed; item is logically valid and medically sound.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. The vignette describes a 45-year-old paraplegic with stage 4 sacral pressure ulcer, positive probe-to-bone test, and MRI showing marrow edema limited to cortex (cortical osteomyelitis), with failed 4-week antibiotic trial. Key discriminating findings: (1) stage 4 ulcer with bone involvement, (2) cortical-only osteomyelitis (not medullary), (3) failed conservative management. The question asks for definitive management. Option B (surgical debridement with burr drilling, VAC, then gluteal myocutaneous flap) is the standard staged approach for cortical osteomyelitis in pressure ulcers: debride infected bone to bleeding cortex, prepare wound bed with negative pressure, then provide durable muscle flap coverage. Option A (suppressive antibiotics) fails in most cases without source control. Option C (partial sacrectomy) is overly aggressive for cortical-only disease; reserved for medullary involvement. Option D (biopsy and prolonged antibiotics) lacks surgical source control. Option E (free latissimus flap) is unnecessarily complex when local gluteal muscle is available. The keyed answer aligns with standard reconstructive ladder principles and pressure ulcer management guidelines. Medical accuracy: The staged approach and flap selection are appropriate. Minor issue: 85% healing rate cited in rationale is optimistic but within reported ranges. Minimal fix: None needed; item is logically valid and medically sound.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-018", "question": "A 35-year-old man sustains deep partial-thickness burns to both upper eyelids with early cicatricial ectropion and 3 mm scleral show. The tarsal plate is intact but contracted. What is the optimal reconstruction timing and technique?", "options": ["A) Immediate full-thickness skin graft from supraclavicular fossa with tarsorrhaphy", "B) Delayed reconstruction at 6 months with split-thickness skin graft and Frost suture", "C) Immediate Mustarde cheek advancement flap with cartilage graft", "D) Delayed full-thickness skin graft from postauricular area with tarsal release", "E) Immediate temporoparietal fascia flap with skin graft"], "answer": "D", "answer_index": 3, "explanation": "For post-burn eyelid ectropion with tarsal contracture, delayed reconstruction at 6-12 months with full-thickness postauricular skin graft after complete tarsal release provides optimal color match and prevents retraction. Immediate grafting fails due to ongoing inflammation and inadequate recipient bed vascularity. Mustarde flaps are excessive for isolated eyelid involvement, and temporoparietal fascia is reserved for total eyelid loss. Postauricular skin has thinner dermis than supraclavicular, better matching eyelid architecture.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes early cicatricial ectropion with 3mm scleral show and intact but contracted tarsal plate. The critical missing detail is the timing of presentation relative to injury—\\\"early\\\" is ambiguous (days? weeks?). Key stem clues: deep partial-thickness burns, early ectropion, intact tarsal plate. The keyed answer (D) advocates delayed reconstruction at 6 months with full-thickness postauricular graft and tarsal release. However, option A (immediate full-thickness supraclavicular graft with tarsorrhaphy) is also defensible for acute cicatricial ectropion requiring urgent corneal protection. The rationale correctly notes inflammation concerns but doesn't address that \\\"early\\\" ectropion with 3mm scleral show may require immediate intervention to prevent exposure keratopathy. Medical accuracy issues: The 6-month delay may be excessive for symptomatic ectropion; 3-6 months is more typical. The distinction between supraclavicular versus postauricular donor sites is overstated—both provide acceptable full-thickness grafts. Minimal fix: Specify timing post-injury (e.g., \\\"2 weeks post-burn\\\") and clarify presence/absence of corneal exposure symptoms to definitively favor immediate versus delayed approach.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes early cicatricial ectropion with 3mm scleral show and intact but contracted tarsal plate. The critical missing detail is the timing of presentation relative to injury—\"early\" is ambiguous (days? weeks?). Key stem clues: deep partial-thickness burns, early ectropion, intact tarsal plate. The keyed answer (D) advocates delayed reconstruction at 6 months with full-thickness postauricular graft and tarsal release. However, option A (immediate full-thickness supraclavicular graft with tarsorrhaphy) is also defensible for acute cicatricial ectropion requiring urgent corneal protection. The rationale correctly notes inflammation concerns but doesn't address that \"early\" ectropion with 3mm scleral show may require immediate intervention to prevent exposure keratopathy. Medical accuracy issues: The 6-month delay may be excessive for symptomatic ectropion; 3-6 months is more typical. The distinction between supraclavicular versus postauricular donor sites is overstated—both provide acceptable full-thickness grafts. Minimal fix: Specify timing post-injury (e.g., \"2 weeks post-burn\") and clarify presence/absence of corneal exposure symptoms to definitively favor immediate versus delayed approach.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-019", "question": "A 12-year-old girl with Chiari I malformation and holocord syringomyelia undergoes posterior fossa decompression. Intraoperative ultrasound after bone removal shows persistent syrinx with tonsillar pulsation. What is the next step?", "options": ["A) Perform duraplasty with bovine pericardial graft and tonsillectomy", "B) Perform duraplasty with autologous pericranial graft without tonsillectomy", "C) Extend bone decompression to C2 without dural opening", "D) Perform tonsillectomy only without duraplasty", "E) Place syringosubarachnoid shunt"], "answer": "B", "answer_index": 1, "explanation": "When intraoperative ultrasound shows persistent syrinx after bone decompression, duraplasty with autologous pericranial graft restores normal CSF flow dynamics without tonsillectomy. Autologous graft reduces pseudomeningocele risk compared to allograft. Tonsillectomy adds morbidity without additional syrinx resolution when duraplasty alone achieves flow restoration. Syringosubarachnoid shunt is reserved for failed decompression, and extending bone removal is ineffective without addressing dural restriction.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 12-year-old with Chiari I and holocord syringomyelia undergoing posterior fossa decompression; intraoperative ultrasound after bone removal shows persistent syrinx with tonsillar pulsation. Key discriminating finding: persistent syrinx despite bone decompression suggests inadequate CSF flow restoration. The question asks for next step. Keyed answer B (duraplasty with autologous pericranial graft without tonsillectomy) assumes duraplasty alone suffices. However, Option A (duraplasty with bovine pericardial graft and tonsillectomy) is equally defensible. Current neurosurgical practice shows significant variation: some surgeons perform duraplasty alone, others add cerebellar tonsil reduction/coagulation when tonsillar pulsation persists. The rationale's claim that 'tonsillectomy adds morbidity without additional syrinx resolution' is not universally accepted—many centers routinely perform tonsillar coagulation/reduction with duraplasty for Chiari I with syringomyelia. The graft choice (autologous vs bovine pericardium) is also debated; both are widely used with comparable outcomes. The stem lacks critical details (degree of tonsillar descent, syrinx size, prior symptoms) needed to definitively choose between duraplasty-alone versus duraplasty-plus-tonsillectomy. Medical accuracy: score 3—reflects one valid approach but presents it as uniquely correct when practice varies. Minimal fix: specify 'tonsillar descent <5mm' or add clinical context favoring duraplasty-alone.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 12-year-old with Chiari I and holocord syringomyelia undergoing posterior fossa decompression; intraoperative ultrasound after bone removal shows persistent syrinx with tonsillar pulsation. Key discriminating finding: persistent syrinx despite bone decompression suggests inadequate CSF flow restoration. The question asks for next step. Keyed answer B (duraplasty with autologous pericranial graft without tonsillectomy) assumes duraplasty alone suffices. However, Option A (duraplasty with bovine pericardial graft and tonsillectomy) is equally defensible. Current neurosurgical practice shows significant variation: some surgeons perform duraplasty alone, others add cerebellar tonsil reduction/coagulation when tonsillar pulsation persists. The rationale's claim that 'tonsillectomy adds morbidity without additional syrinx resolution' is not universally accepted—many centers routinely perform tonsillar coagulation/reduction with duraplasty for Chiari I with syringomyelia. The graft choice (autologous vs bovine pericardium) is also debated; both are widely used with comparable outcomes. The stem lacks critical details (degree of tonsillar descent, syrinx size, prior symptoms) needed to definitively choose between duraplasty-alone versus duraplasty-plus-tonsillectomy. Medical accuracy: score 3—reflects one valid approach but presents it as uniquely correct when practice varies. Minimal fix: specify 'tonsillar descent <5mm' or add clinical context favoring duraplasty-alone.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-020", "question": "A 62-year-old man with T2N0M0 glottic carcinoma involving the anterior commissure is scheduled for definitive radiation therapy. He has good performance status and no comorbidities. What is the optimal fractionation scheme to maximize local control?", "options": ["A) 70 Gy in 35 fractions over 7 weeks with concurrent cisplatin", "B) 66 Gy in 33 fractions over 6.5 weeks with concurrent cetuximab", "C) 72 Gy in 42 fractions using concomitant boost over 6 weeks", "D) 60 Gy in 30 fractions over 6 weeks with hyperfractionation", "E) 50 Gy in 20 fractions over 4 weeks with hypofractionation"], "answer": "C", "answer_index": 2, "explanation": "For T2 glottic cancer with anterior commissure involvement, altered fractionation with concomitant boost (72 Gy/42 fractions/6 weeks) improves 5-year local control to 85% versus 70% with standard fractionation, without increasing late toxicity. The anterior commissure is a sanctuary site with poor vascularity, requiring higher biologically effective dose. Concurrent chemotherapy is not indicated for T2 disease and increases mucositis. Hypofractionation is reserved for early T1 lesions without commissure involvement.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible)\\nVerdict on keyed answer: Not uniquely determinable\\n\\nThe question asks for optimal fractionation for T2N0M0 glottic cancer with anterior commissure involvement. Key stem clues: T2 disease, anterior commissure involvement, good performance status, no comorbidities.\\n\\nKeyed answer C (72 Gy/42 fractions concomitant boost) is supported by the rationale citing improved local control (85% vs 70%). However, option A (70 Gy/35 fractions with cisplatin) represents standard-of-care concurrent chemoradiation, which is widely accepted for T2 laryngeal cancer and supported by major trials (RTOG 91-11) showing superior outcomes with combined modality treatment.\\n\\nThe rationale states \\\"concurrent chemotherapy is not indicated for T2 disease,\\\" but this contradicts established guidelines. NCCN and other major guidelines support concurrent chemoradiation for T2 laryngeal cancer, particularly with adverse features like anterior commissure involvement. Both options A and C are defensible: A follows standard guidelines for T2 disease, while C represents altered fractionation that may benefit anterior commissure involvement specifically.\\n\\nMedical accuracy issue: The claim that chemotherapy is not indicated for T2 disease is incorrect per current standards.\\n\\nMinimal fix: Specify T1 disease (not T2) or clarify that the question seeks altered fractionation specifically, excluding chemoradiation from consideration.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible)\nVerdict on keyed answer: Not uniquely determinable\n\nThe question asks for optimal fractionation for T2N0M0 glottic cancer with anterior commissure involvement. Key stem clues: T2 disease, anterior commissure involvement, good performance status, no comorbidities.\n\nKeyed answer C (72 Gy/42 fractions concomitant boost) is supported by the rationale citing improved local control (85% vs 70%). However, option A (70 Gy/35 fractions with cisplatin) represents standard-of-care concurrent chemoradiation, which is widely accepted for T2 laryngeal cancer and supported by major trials (RTOG 91-11) showing superior outcomes with combined modality treatment.\n\nThe rationale states \"concurrent chemotherapy is not indicated for T2 disease,\" but this contradicts established guidelines. NCCN and other major guidelines support concurrent chemoradiation for T2 laryngeal cancer, particularly with adverse features like anterior commissure involvement. Both options A and C are defensible: A follows standard guidelines for T2 disease, while C represents altered fractionation that may benefit anterior commissure involvement specifically.\n\nMedical accuracy issue: The claim that chemotherapy is not indicated for T2 disease is incorrect per current standards.\n\nMinimal fix: Specify T1 disease (not T2) or clarify that the question seeks altered fractionation specifically, excluding chemoradiation from consideration.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}]